Journal of Oncological Sciences (JOS) is the official journal of Turkish Society of Medical Oncology. The journal is an international quarterly periodical published on independent, unbiased, double-blinded and peer-review principles. The language of publication is English. 

JOS is published every 4 months (total of 3 issues per year).

With a large international editorial board of experts, JOS aims to advance clinically-relevant knowledge of cancer, and improve prevention, diagnosis and treatment of malignant disease. It provides an integrated view of oncology across all disciplines. The emphasis will be on publishing high quality papers rapidly and freely available to researchers worldwide.

JOS is an international multidisciplinary oncology journal, which publishes high quality original research, reviews, short communications (as letters), case reports and editorial comments on basic and preclinical cancer research, translational oncology, clinical oncology including medical oncology, pediatric oncology, radiation oncology, surgical oncology, therapeutic radiology and cancer epidemiology and prevention.

The target readership includes academic members, specialists, residents, and general practitioners working in the fields of oncology, radiation oncology, nuclear medicine, and internal medicine.

The editorial and publication processes of the journal are conducted in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the European Association of Science Editors (EASE), and the Committee on Publication Ethics (COPE).

The requirements for submission of manuscripts and detailed information about the evaluation process are available in the published journal and also as ‘Instructions’ on the website (

Papers will be submitted in submission web site. Editorial office will rapidly review papers and those of insufficient quality will be returned to the author 3 weeks, while those with sufficient priority will be passed to external review.